Robert Hamilton Pierce Sensei Biotherapeutics, Inc. (SNSE) insider trading activity

SNSE Quotes by TradingView

Robert Hamilton Pierce is Chief R&D Officer of Sensei Biotherapeutics, Inc.. Currently has a direct ownership of 21,000 shares of SNSE, which is worth approximately $10,500. The most recent transaction as insider was on Feb 15, 2022, when has been sold 21,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21K
0% 3M change
0% 12M change
Total Value Held $10,500

Robert Hamilton Pierce Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 15 2022
BUY
Grant, award, or other acquisition
-
21,000 Added 50.0%
21,000 Common Stock
RHP

Robert Hamilton Pierce

Chief R&D Officer
Rockville, MD

Track Institutional and Insider Activities on SNSE

Follow Sensei Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SNSE shares.

Notify only if

Insider Trading

Get notified when an Sensei Biotherapeutics, Inc. insider buys or sells SNSE shares.

Notify only if

News

Receive news related to Sensei Biotherapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SNSE